sclerosis (scle-ro-sis) - is the induration or hardening, especially from inflammation and in diseases of the interstitial substance; applied chiefly to such hardening of the nervous system primarily attributed to multiple sclerosis.
NEWSLETTERS
VOLUME 13 NEWSLETTER 7
Esperanza Peptide has recently opened their own administration and clinic booking centre in Darlington. The growth of Esperanza and the amazing popularity of the Esperanza NeuroPeptide treatment in the UK has been met with a decision to dedicate an administration and booking centre to better serve those that require information and booking their clinic dates and times. Esperanza has also expanded its regional clinic availability to over 25 clinics in the UK.
The Darlington offices will also be the base of Dr. Peter McCann who has recently joined the Esperanza health practitioner team and will be administering the Esperanza NeuroPeptide treatment at regional clinics. The new centre is staffed by Brian Campbell, Jackie Kynman and Liz Campbell.
Brian Campbell the manager of the new administration centre said about the new expansion: "I have been associated with Esperanza Peptide for over 5 years now and have known Gerry Gallagher, Esperanza's MD, for about 8 years. I visited The Bahamas and the Esperanza and manufacturing facilities in Freeport in 2005 and am now delighted to be heading up this exciting growth and expansion phase here in the UK and eventually into many European countries!
I have seen first-hand that the Esperanza NeuroPeptide treatment is a fabulous and much needed treatment for multiple sclerosis. Our commitmentis to make obtaining information and booking clinic dates and times as easy and accommodating as we can for any patient wishing to contact us"
The new information and booking telephone line is: 01325 254420
Brian Campbell, Manager of the Esperanza Clinic Booking and Information Centre in Darlington
This Website, the website contents, the Esperanza logo and the animated Esperanza logo depicted on this website are copyright, registered and exclusively owned by Esperanza Peptide Ltd.
